Biotechnology News

Fri, 2013-08-09 11:01

BALTIMORE--(BUSINESS WIRE)--Cerecor has been issued a US patent covering composition claims for its centrally-acting antitussive, FP01, currently in a Phase 2b study for the treatment of chronic cough.

Fri, 2013-08-09 11:01

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical announced today the full market launch of the Tritium Sternal Cable Plating System for closing median sternotomies following open heart procedures.

Fri, 2013-08-09 11:01

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--New market report names Quintiles as a preferred provider for Phase I studies.

Fri, 2013-08-09 11:01

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix second quarter financial results

Fri, 2013-08-09 11:01

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its financial results and business update for the second quarter ended June 30, 2013...

Fri, 2013-08-09 08:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference

Fri, 2013-08-09 04:00

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that the European Commission (EC) has granted approval for Pomalidomide Celgene®▼(pomalidomide), in...

Thu, 2013-08-08 21:00

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal diseases and disorders, today announced the planned spin-off of its FV-100 assets into a separate publicly traded company....

Thu, 2013-08-08 18:01

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the following investor conferences: Wedbush Lifesciences...

Thu, 2013-08-08 18:01

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the second...

Thu, 2013-08-08 18:01

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today reports its second quarter 2013 financial results and provides updates on clinical development and commercialization activities.

Thu, 2013-08-08 18:01

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported second quarter 2013 adjusted earnings per diluted share of $0.23, compared to adjusted earnings of $0.61 for the same quarter of 2012. On a GAAP basis,...

Thu, 2013-08-08 18:01

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended June 30, 2013. Revenues for the second quarter of 2013 were $19.2 million compared to $1.8 million for the same...

Thu, 2013-08-08 18:01

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the second quarter ended June 30, 2013. “We had a busy second quarter as we finalized preparations for our NDA for tavaborole,...

Thu, 2013-08-08 18:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter 2013, and company highlights. “This was an exceptional...

Thu, 2013-08-08 18:01

SEATTLE--(BUSINESS WIRE)--August 8, 2013--Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2013. Net product revenue for the quarter was $73.3 million compared to $80.0 million for the quarter ended...

Thu, 2013-08-08 18:01

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June...

Thu, 2013-08-08 18:01

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced it received a not approvable letter from the Food & Drug Administration (FDA) in response to its Pre-Market Approval (PMA) application for Augment®...

Thu, 2013-08-08 18:01

WASHINGTON--(BUSINESS WIRE)--Registration for the 12th Annual BIO Investor Forum has opened, a biotech conference focused on investment strategies for early stage and established private companies and emerging public companies.

Thu, 2013-08-08 18:01

MIAMI--(BUSINESS WIRE)--Stemsynergy Therapeutics, Inc., today announced a breakthrough study for treating synovial sarcoma, an aggressive soft tissue cancer that predominantly affects teenagers and young adults. Stemsynergy is a privately held...

Thu, 2013-08-08 18:01

ARLINGTON, Va.--(BUSINESS WIRE)--Biotech industry infographic debunks genetically modified food myths.

Thu, 2013-08-08 18:01

MINNEAPOLIS--(BUSINESS WIRE)--SightLine Partners, a leading manager of private equity funds that provide creative financing solutions to late-stage medical technology companies, today announced the closing of SightLine Healthcare Opportunity Fund...

Thu, 2013-08-08 12:02

HOPKINTON, Mass.--(BUSINESS WIRE)--See how a 50 year old US manufacturer of industrial fluid dispensing equipment has used smart technology to sell the same machine to dispense human cells for growing organs: Fishman's SmartDispenser.

Thu, 2013-08-08 12:02

NISKAYUNA, N.Y.--(BUSINESS WIRE)--Similar to a pregnancy test, GE and the Univ. of Wash. are developing a paper-based, playing card size instrument that would enable field-based testing for a wide range of infectious diseases.

Thu, 2013-08-08 12:02

SOUTH SAN FRANCISCO, Calif. & HUNTSVILLE, Ala.--(BUSINESS WIRE)--Sequenta and iRepertoire announced that Sequenta has gained exclusive rights to the iRepertoire intellectual property on novel methods of immune cell sequencing for minimal...

Thu, 2013-08-08 12:02

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. will participate in the Canaccord Genuity 33rd Annual Growth Conference on Aug. 14 at 1:30 p.m. Eastern Time.

Thu, 2013-08-08 12:02

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical has secured $27 million in financing from its current investors along with new investors Covidien Ventures, Action Potential Venture Capital Limited (new GSK bioelectronic med fund).

Thu, 2013-08-08 12:02

WALTHAM, Mass.--(BUSINESS WIRE)--Guillaume Pfefer, Ph.D., Kala’s Chief Executive Officer, will present at the Canaccord Genuity Annual Growth Conference in Boston on Wednesday, August 14 at 9:30am ET

Thu, 2013-08-08 12:02

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD today announced it has appointed David Johnston, Ph.D., as executive vice president of global laboratory services. Dr. Johnston directs PPD’s industry-leading, comprehensive laboratory services.

Thu, 2013-08-08 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported its second quarter 2013 financial results and provided an update on its clinical pipeline. Infinity today announced that, in the fourth quarter of...

Thu, 2013-08-08 09:00

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for the quarter ended June 30, 2013.

Thu, 2013-08-08 09:00

LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, issued the following Letter to Shareholders today: Dear Shareholders, Now that the merger between Genesis...

Thu, 2013-08-08 09:00

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, today announced its participation in the Jefferies Global Industrials Conference and the Pacific Crest Global Technology...

Thu, 2013-08-08 09:00

SAO PAULO & SAN CARLOS, Calif.--(BUSINESS WIRE)--DASA Group and Natera today announced that DASA Group will begin offering Natera’s non-invasive prenatal test (NIPT) Panorama™ for the detection of genetic syndromes common in the population,...

Thu, 2013-08-08 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Reports Second Quarter 2013 Financial Results

Thu, 2013-08-08 09:00

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the second quarter ended June 30, 2013. “The fact that we met all of our goals for the BCX4161 Phase 1 trial and...

Thu, 2013-08-08 09:00

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Initiates Search for Medical Business Consultant

Thu, 2013-08-08 05:00

BEERSE, Belgium--(BUSINESS WIRE)--VELCADE has been approved by the EC for use as induction therapy (a first therapeutic option) in patients with multiple myeloma eligible for stem cell transplantation.

Thu, 2013-08-08 05:00

RICHMOND, Va. & SYDNEY & LONDON--(BUSINESS WIRE)--AmpliPhi BioSciences yesterday presented data on bacteriophages to treat P. aeruginosa at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington.

Thu, 2013-08-08 00:01

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced the pricing of an...

Wed, 2013-08-07 20:01

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three month period ended June 30, 2013. Quarter ended June 30, 2013 Highlights -...

Wed, 2013-08-07 20:01

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Reports Fiscal 2013 Third Quarter Financial Results and has Conference Call Today at 4:30 p.m. Eastern Time

Wed, 2013-08-07 20:01

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Second Quarter 2013 Results